Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
Kevin L WinthropMichael E WeinblattJoan BathonGerd R BurmesterPhillip J MeaseLeslie CroffordVivian BykerkMaxime DougadosJames Todd RosenbaumXavier MarietteJoachim SieperFritz MelchersBruce N CronsteinFerry C BreedveldJoachim KaldenJosef S SmolenDaniel FurstPublished in: Annals of the rheumatic diseases (2019)
Unmet needs for new therapies and trial designs, particularly for those with treatment refractory disease, remain a top priority in rheumatology.